What Contributed to the Rapid Growth of the Biomaterials Market Historically?
The Biomaterials Market size has experienced a significant growth over the past several years.
• The market has progressed from $134.31 billion in 2024 to $153.55 billion in 2025, indicating an impressive CAGR of 14.3%.
Factors such as the growing aging population, the use of biomaterials in orthopedic and dental applications, increasing awareness of environmental sustainability, the prevalence of chronic conditions, and the rising demand for medical implants have all contributed to this robust growth.
What's the Forecasted Biomaterials Market Size and Projected Annual Growth Rates?
The biomaterials market is predicted to see sustained growth in the coming years.
• With a projected market size of $262.56 billion in 2029, the market will expand at a CAGR of 14.4%.
The forecasted growth is driven by shifting consumer preferences, surge in demand for biomaterials in 3D printing and additive manufacturing, expansion of the biodegradable and bioresorbable biomaterials segment, and the increasing use of biomaterials in drug delivery systems for personalized medicine, wound care, and tissue regeneration. Key trends propelling the market forward include the development of smart biomaterials with responsive and adaptive properties, an emphasis on precision medicine leading to customized biomaterial solutions, and the integration of nanotechnology for enhanced functionality.
What are the Key Drivers for the Growth of the Biomaterials Market?
The rising incidence of cardiovascular diseases is a major driver of the biomaterials market. The increasing prevalence of cardiovascular disorders, caused by factors such as high blood pressure, smoking, high cholesterol, and inactivity, has resulted in increased demand for products such as heart valves, cardiopulmonary bypass systems, stents, vascular grafts, complete artificial hearts, and pacemakers. For instance, according to the Centers for Disease Control and Prevention, coronary artery disease (CAD) was responsible for killing 375,476 people in 2021.
What is the Market Segmentation for the Biomaterials Industry?
The key market segments of the biomaterials market surveyed in this report include:
1) By Type: Metallic Biomaterial, Polymeric Biomaterials, Natural Biomaterials, Ceramics.
2) By Application: Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System.
3) By End Use: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users.
Pre-Book The Biomaterials Market Report For Swift Delivery And Comprehensive Insights Here
What Are the Trends Shaping the Biomaterials Market?
Strategic partnerships are emerging as a key trend in the biomaterials market. For instance, IFF, a US-based Corporation, launched the Designed Enzymatic Biomaterials (DEB) technology platform, in June 2023, which allows for precise drug delivery and plays a crucial role in tissue engineering. This technology, which enables the customization of biobased polysaccharides, is enhancing the market adoption of biomaterials.
Who are the Key Players in the Biomaterials Industry?
The main players in the biomaterials market include the following:
• Corbion N V
• Evonik Industries AG
• Heraeus Medical Components LLC
• Berkeley Advanced Biomaterials Inc.
• Zimmer Biomet Holdings Inc.
• DSM Biomedical BV
• PolyNovo Limited
Which Region Was the Largest in the Biomaterials Market?
North America held the largest portion of the biomaterials market in 2024. However, the other regions covered in the report - Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, Africa - also hold potential for future growth.
